Latest News and Press Releases
Want to stay updated on the latest news?
-
PASADENA and PALO ALTO, Calif., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Autism Learning Partners ("ALP"), a national leader in the treatment of autism and other developmental disabilities, and Cognoa, the...
-
Palo Alto, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that three company executives will be on...
-
Palo Alto, Calif. and London, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, has been named to the 2020 Global Digital...
-
Austin, Texas, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Austin Regional Clinic (ARC) is partnering with Cognoa, a leading pediatric behavioral health company, on a national multi-site clinical trial to...
-
Austin, Texas, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Austin Regional Clinic (ARC) is partnering with Cognoa, a leading pediatric behavioral health company, on a national multi-site clinical trial to...
-
Palo Alto, Calif., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Cognoa, a company at the forefront of pediatric behavioral health, has won the Fierce Innovation Life Science Award for Technology Innovation....
-
Palo Alto, Calif., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Cognoa, a company at the forefront of pediatric behavioral health, announced today that it has been selected as a finalist in Questex’s Fierce...
-
Palo Alto, Calif., Dec. 02, 2019 (GLOBE NEWSWIRE) -- Cognoa, a company at the forefront of pediatric behavioral health, announced today that James (Jim) H. Welch has been appointed Chief Financial...
-
PALO ALTO, Calif., April 10, 2019 (GLOBE NEWSWIRE) -- Cognoa, a company at the forefront of digital behavioral health for children, today announces it has exclusively licensed technology from the...
-
PALO ALTO, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Cognoa, a company at the forefront of digital behavioral health for children, today announces it has received Breakthrough Device designations...